BI Asset Management Fondsmaeglerselskab’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
BI Asset Management Fondsmaeglerselskab's DGX Position: Q2 2026 in Review
BI Asset Management Fondsmaeglerselskab increased its Quest Diagnostics (DGX) stake by 4.3% in Q2 2026, buying an estimated $64.2K and bringing the position to 7,925 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #451.
BI Asset Management Fondsmaeglerselskab first reported a position in DGX in Q1 2020 and has held it in 20 quarters since. The position peaked at $14M in Q4 2022. 772 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab held 7,925 shares of Quest Diagnostics worth $1.68M as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab bought 327 Quest Diagnostics shares in Q2 2026, an estimated $64.2K.
- Quest Diagnostics made up 0.01% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #451 holding.
- BI Asset Management Fondsmaeglerselskab first reported a position in Quest Diagnostics in Q1 2020 and has held it in 20 quarters since.
- BI Asset Management Fondsmaeglerselskab's Quest Diagnostics position peaked at $14M in Q4 2022.
- 772 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.